Today: 29 April 2026
Gold price jumps as tariff fears swell; traders brace for Iran talks and U.S. jobs report
25 February 2026
2 mins read

Gold price jumps as tariff fears swell; traders brace for Iran talks and U.S. jobs report

New York, February 25, 2026, 17:23 (EST) — After-hours

  • Spot gold gained 1.1%, reaching $5,202.28 an ounce. U.S. gold futures wrapped up the session roughly 1% higher at $5,226.20.
  • Tariffs and Middle East tensions sent investors to bullion, seeking both an inflation shield and a risk hedge.
  • Attention now turns to Thursday’s Geneva talks, with the U.S. jobs report due March 6 also in focus.

Gold pushed higher Wednesday, with spot prices up 1.1% to $5,202.28 an ounce as of 2:00 p.m. ET. U.S. gold futures for April delivery closed around 1% above the previous session at $5,226.20, as shifting U.S. tariff moves and fresh Iran tensions had investors moving into havens. “There’s an inflationary impact from tariffs and high oil prices,” said Bart Melek, global head of commodity strategy at TD Securities. Reuters

Bullion’s still hovering near all-time highs after a scorching rally. On Wednesday, J.P. Morgan bumped its long-term gold target up to $4,500 an ounce, holding steady on its $6,300 forecast for end-2026, citing sustained demand from central banks and investors, plus inflows into gold-backed ETFs. According to the bank, spot gold has climbed roughly 20% this year—on top of a 64%-plus jump in 2025—and notched a three-week peak at $5,248.89 just this Tuesday.

Tariffs are front and center. U.S. Trade Representative Jamieson Greer confirmed the 10% tariff is just the starting point—some countries will see that pop up to 15% or more. The White House is drawing up a proclamation to bump up those temporary levies “where appropriate.” “Right now, we have the 10% tariff. It’ll go up to 15(%) for some,” Greer told reporters. Reuters

Geopolitical tensions continue to drive the action. Iran sounded upbeat about prospects for a third round of discussions with the U.S., noting a “good outlook” as its negotiators traveled to Geneva. U.S. envoy Steve Witkoff and Jared Kushner are expected to sit down with the Iranian team on Thursday, according to Reuters. Reuters

The rally came after a shaky beginning to the week. On Tuesday, gold slipped off a three-week high—profit-takers moved in, and a stronger dollar weighed on prices. Traders kept to the sidelines as they waited for more details on tariff policy and the results of Washington-Tehran negotiations.

Rates are still the other key variable, even as safe-haven flows drive most of the action. Boston Fed President Susan Collins said it’s “quite likely” the Fed will leave its policy rate unchanged “for some time.” The target: 3.5% to 3.75% since the late-January meeting. Gold, which pays no interest, tends to lose some appeal as rates climb. Reuters

Gold’s holding its ground as a haven and an inflation shield, especially with tariff chatter pulling double duty. More policy zigzags? That just brings in more buyers.

The risks aren’t hard to spot. If tariff proposals get diluted, or diplomats in Geneva dial back the rhetoric, or if U.S. yields push up again, that could spark a faster retreat after this month’s climb. With prices hovering near records, profit-taking could hit fast.

The February U.S. jobs numbers land March 6, right at 8:30 a.m. ET—a release known for shaking up rate bets if hiring or wage figures catch anyone off guard.

Stock Market Today

  • Allied Critical Metals Seeks TSX Venture Tier 1 Listing, Grants Equity Awards
    April 29, 2026, 8:44 AM EDT. Allied Critical Metals (OTCQB: ACMIF) has applied to list its common shares on the TSX Venture Exchange (TSX-V) as a Tier 1 mining issuer. The move aims to enhance capital market access for advancing its Borralha and Vila Verde tungsten projects. CEO Roy Bonnell highlighted the listing as a strategic step to unlock shareholder value and boost investor relations. The application awaits TSX-V review and meeting of listing criteria. Concurrently, Allied granted 2.5 million stock options with a $2.32 exercise price, expiring in five years, plus 1 million restricted share units (RSUs). These equity awards, vesting immediately, are subject to a four-month hold per Canadian Securities Exchange rules, reflecting management's alignment with shareholder interests.

Latest article

BigBear.ai Stock Jumps 10% Before Earnings: Why BBAI Is Back on Traders’ Screens

BigBear.ai Stock Jumps 10% Before Earnings: Why BBAI Is Back on Traders’ Screens

29 April 2026
BigBear.ai shares jumped 10.46% to close at $4.12 Tuesday, with trading volume 54% above its three-month average. The company will report first-quarter results after markets close on May 5. Analysts expect a quarterly loss and revenue near $33.6 million. The move comes as AI stocks face pressure following reports of missed targets at OpenAI.
Gas Prices Hit $4.23 as Iran Oil Shock Reaches U.S. Pumps

Gas Prices Hit $4.23 as Iran Oil Shock Reaches U.S. Pumps

29 April 2026
U.S. average gasoline prices rose to $4.229 a gallon Wednesday, up 21 cents from a week ago, AAA reported. Brent crude climbed above $114 as traders reacted to ongoing disruptions near Iran and the Strait of Hormuz. Refineries in the Midwest faced outages, tightening supply. The Federal Reserve is expected to hold rates steady as officials monitor energy-driven inflation.
KPMG’s $60 Million Pentagon Contract Loss Ends Its U.S. Federal Audit Run

KPMG’s $60 Million Pentagon Contract Loss Ends Its U.S. Federal Audit Run

29 April 2026
KPMG will close its U.S. federal government audit business and reassign over 450 staff after losing a $60 million annual Pentagon contract, the Financial Times reported. The firm had audited the Army for nearly a decade, with its latest contract rising to $64 million a year. The Pentagon is shifting to consolidated audits and aims for a clean audit by 2028. KPMG expects to exit federal audit work by 2030.
Netflix stock jumps 6% on Warner bid twist — what investors watch next
Previous Story

Netflix stock jumps 6% on Warner bid twist — what investors watch next

Eli Lilly stock price slips as Zepbound KwikPen FDA nod and Novo trial data keep LLY in focus
Next Story

Eli Lilly stock price slips as Zepbound KwikPen FDA nod and Novo trial data keep LLY in focus

Go toTop